ESTRELLA IMMUNOPHARMA, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-316.2K | $-316.2K | — | — |
| FY2022 | $-1.0M | $-1.0M | — | — |
| FY2023 | $-1.3M | $-1.3M | — | $409.6K |
| FY2024 | $-16.1M | $-16.1M | — | $1.2M |
| FY2025 | $-1.8M | $-1.8M | — | $619.0K |